A Randomized, Single-Blind, Multicenter Study Comparing Pixantrone + Rituximab with an Investigator’s Choice of Single Agent Rituximab or Gemcitabine + Rituximab in Non-Stem Cell Transplant Eligible Patients with Aggressive B-cell Non-Hodgkins Lymphoma Who Have Relapsed after Therapy with CHOP-R or an Equivalent Regimen - Regional Cancer Care Associates LLC

Clinical Trials

A Randomized, Single-Blind, Multicenter Study Comparing Pixantrone + Rituximab with an Investigator’s Choice of Single Agent Rituximab or Gemcitabine + Rituximab in Non-Stem Cell Transplant Eligible Patients with Aggressive B-cell Non-Hodgkins Lymphoma Who Have Relapsed after Therapy with CHOP-R or an Equivalent Regimen

Type of Cancer
Lymphoma
Locations
Bethesda
Sponsor
Protocol Number
PIX306
Cancer Diagnosis
To Learn More Call
201-510-0910